Nicholas P. Anagnou

Biomedical Research Foundation of the Academy of Athens — Greece

Medicine · Health Sciences

41h-index7.7kcitations171works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hemoglobinopathies and Related Disorders(25), Bladder and Urothelial Cancer Treatments(18), Mesenchymal stem cell research(14), Virus-based gene therapy research(14), RNA modifications and cancer(13)

Publications170 total

m6A mRNA Methylation in Hematopoiesis: The Importance of Writing, Erasing, and Reading
Cells·2025· 2 citedOpen Access
m<sup>6</sup>A mRNA Methylation in Hematopoiesis: The Importance of Writing, Erasing, and Reading
Preprints.org·2025· 1 citedOpen Access
The Combined Treatment of Btkis with Venetoclax Exhibits an Enhanced Therapeutic Effect on Waldenström Macroglobulinemia Cells Bearing CXCR4 Mutations
Blood·2024Open Access
<i>CXCR4 S338X</i> Promotes Resistance to Second Generation BTK Inhibitor and BCL-2 Inhibitor in WM Cells
Blood·2023
Developing Oncolytic Viruses for the Treatment of Cervical Cancer
Cells·2023· 13 citedOpen Access
Supplementary Table S5 from Development and Validation of Urine-based Peptide Biomarker Panels for Detecting Bladder Cancer in a Multi-center Study
2023Open Access
Supplementary Table S7 from Development and Validation of Urine-based Peptide Biomarker Panels for Detecting Bladder Cancer in a Multi-center Study
2023Open Access
Supplementary Table S3 from Development and Validation of Urine-based Peptide Biomarker Panels for Detecting Bladder Cancer in a Multi-center Study
2023Open Access
Data from Development and Validation of Urine-based Peptide Biomarker Panels for Detecting Bladder Cancer in a Multi-center Study
2023Open Access
Data from Development and Validation of Urine-based Peptide Biomarker Panels for Detecting Bladder Cancer in a Multi-center Study
2023Open Access
Supplementary Table S5 from Development and Validation of Urine-based Peptide Biomarker Panels for Detecting Bladder Cancer in a Multi-center Study
2023Open Access
Supplementary Table S3 from Development and Validation of Urine-based Peptide Biomarker Panels for Detecting Bladder Cancer in a Multi-center Study
2023Open Access
Supplementary Table S2 from Development and Validation of Urine-based Peptide Biomarker Panels for Detecting Bladder Cancer in a Multi-center Study
2023Open Access
Supplementary Table S1 from Development and Validation of Urine-based Peptide Biomarker Panels for Detecting Bladder Cancer in a Multi-center Study
2023Open Access
Supplementary Table S1 from Development and Validation of Urine-based Peptide Biomarker Panels for Detecting Bladder Cancer in a Multi-center Study
2023Open Access
Supplementary Table S2 from Development and Validation of Urine-based Peptide Biomarker Panels for Detecting Bladder Cancer in a Multi-center Study
2023Open Access
Supplementary Table S7 from Development and Validation of Urine-based Peptide Biomarker Panels for Detecting Bladder Cancer in a Multi-center Study
2023Open Access
Supplementary Table S6 from Development and Validation of Urine-based Peptide Biomarker Panels for Detecting Bladder Cancer in a Multi-center Study
2023Open Access
Supplementary Table S4 from Development and Validation of Urine-based Peptide Biomarker Panels for Detecting Bladder Cancer in a Multi-center Study
2023Open Access
Supplementary Table S8 from Development and Validation of Urine-based Peptide Biomarker Panels for Detecting Bladder Cancer in a Multi-center Study
2023Open Access
page 1 of 9Next →

Frequent Co-authors

Kalliopi I. Pappa(24), Maria Gazouli(12), Maria G. Roubelakis(12), Emmanuel Michalodimitrakis(7), Ourania Trohatou(7), Antonia Vlahou(6), Manousos Makridakis(6), Vasiliki Bitsika(5), Dimitra Zagoura(5), Arthur W. Nienhuis(4), A. Antsaklis(4), Toomas Kivisild(4), Helle-Viivi Tolk(4), Maere Reidla(4), Ene Metspalu(4), Э. К. Хуснутдинова(4), Vladislava Gusar(4), Elena Grechanina(4), Jüri Parik(4), Erwan Pennarun(4)